Thanks - the company is Cynata ASX CYP but a long long way back in terms of where it is at. Have a phase 1 trial with preliminary results that are positive as you would expect. But a long long way to go. Mesoblast is going to beat it to market by many, many years that is if Cynata ever gets it there.
Cheers
Add to My Watchlist
What is My Watchlist?
